Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction

The purpose of this study was to determine the mechanisms responsible for reduced aerobic capacity (peak Vo(2)) in patients with heart failure with preserved ejection fraction (HFPEF). HFPEF is the predominant form of heart failure in older persons. Exercise intolerance is the primary symptom among...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Journal of the American College of Cardiology Ročník 58; číslo 3; s. 265
Hlavní autoři: Haykowsky, Mark J, Brubaker, Peter H, John, Jerry M, Stewart, Kathryn P, Morgan, Timothy M, Kitzman, Dalane W
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States 12.07.2011
Témata:
ISSN:1558-3597, 1558-3597
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract The purpose of this study was to determine the mechanisms responsible for reduced aerobic capacity (peak Vo(2)) in patients with heart failure with preserved ejection fraction (HFPEF). HFPEF is the predominant form of heart failure in older persons. Exercise intolerance is the primary symptom among patients with HFPEF and a major determinant of reduced quality of life. In contrast to patients with heart failure and reduced ejection fraction, the mechanism of exercise intolerance in HFPEF is less well understood. Left ventricular volumes (2-dimensional echocardiography), cardiac output, Vo(2), and calculated arterial-venous oxygen content difference (A-Vo(2) Diff) were measured at rest and during incremental, exhaustive upright cycle exercise in 48 HFPEF patients (age 69 ± 6 years) and 25 healthy age-matched controls. In HFPEF patients compared with healthy controls, Vo(2) was reduced at peak exercise (14.3 ± 0.5 ml·kg·min(-1) vs. 20.4 ± 0.6 ml·kg·min(-1); p < 0.0001) and was associated with a reduced peak cardiac output (6.3 ± 0.2 l·min(-1) vs. 7.6 ± 0.2 l·min(-1); p < 0.0001) and A-Vo(2) Diff (17 ± 0.4 ml·dl(-1) vs. 19 ± 0.4 ml·dl(-1), p < 0.0007). The strongest independent predictor of peak Vo(2) was the change in A-Vo(2) Diff from rest to peak exercise (A-Vo(2) Diff reserve) for both HFPEF patients (partial correlate, 0.58; standardized β coefficient, 0.66; p = 0.0002) and healthy controls (partial correlate, 0.61; standardized β coefficient, 0.41; p = 0.005). Both reduced cardiac output and A-Vo(2) Diff contribute significantly to the severe exercise intolerance in elderly HFPEF patients. The finding that A-Vo(2) Diff reserve is an independent predictor of peak Vo(2) suggests that peripheral, noncardiac factors are important contributors to exercise intolerance in these patients.
AbstractList The purpose of this study was to determine the mechanisms responsible for reduced aerobic capacity (peak Vo(2)) in patients with heart failure with preserved ejection fraction (HFPEF).OBJECTIVESThe purpose of this study was to determine the mechanisms responsible for reduced aerobic capacity (peak Vo(2)) in patients with heart failure with preserved ejection fraction (HFPEF).HFPEF is the predominant form of heart failure in older persons. Exercise intolerance is the primary symptom among patients with HFPEF and a major determinant of reduced quality of life. In contrast to patients with heart failure and reduced ejection fraction, the mechanism of exercise intolerance in HFPEF is less well understood.BACKGROUNDHFPEF is the predominant form of heart failure in older persons. Exercise intolerance is the primary symptom among patients with HFPEF and a major determinant of reduced quality of life. In contrast to patients with heart failure and reduced ejection fraction, the mechanism of exercise intolerance in HFPEF is less well understood.Left ventricular volumes (2-dimensional echocardiography), cardiac output, Vo(2), and calculated arterial-venous oxygen content difference (A-Vo(2) Diff) were measured at rest and during incremental, exhaustive upright cycle exercise in 48 HFPEF patients (age 69 ± 6 years) and 25 healthy age-matched controls.METHODSLeft ventricular volumes (2-dimensional echocardiography), cardiac output, Vo(2), and calculated arterial-venous oxygen content difference (A-Vo(2) Diff) were measured at rest and during incremental, exhaustive upright cycle exercise in 48 HFPEF patients (age 69 ± 6 years) and 25 healthy age-matched controls.In HFPEF patients compared with healthy controls, Vo(2) was reduced at peak exercise (14.3 ± 0.5 ml·kg·min(-1) vs. 20.4 ± 0.6 ml·kg·min(-1); p < 0.0001) and was associated with a reduced peak cardiac output (6.3 ± 0.2 l·min(-1) vs. 7.6 ± 0.2 l·min(-1); p < 0.0001) and A-Vo(2) Diff (17 ± 0.4 ml·dl(-1) vs. 19 ± 0.4 ml·dl(-1), p < 0.0007). The strongest independent predictor of peak Vo(2) was the change in A-Vo(2) Diff from rest to peak exercise (A-Vo(2) Diff reserve) for both HFPEF patients (partial correlate, 0.58; standardized β coefficient, 0.66; p = 0.0002) and healthy controls (partial correlate, 0.61; standardized β coefficient, 0.41; p = 0.005).RESULTSIn HFPEF patients compared with healthy controls, Vo(2) was reduced at peak exercise (14.3 ± 0.5 ml·kg·min(-1) vs. 20.4 ± 0.6 ml·kg·min(-1); p < 0.0001) and was associated with a reduced peak cardiac output (6.3 ± 0.2 l·min(-1) vs. 7.6 ± 0.2 l·min(-1); p < 0.0001) and A-Vo(2) Diff (17 ± 0.4 ml·dl(-1) vs. 19 ± 0.4 ml·dl(-1), p < 0.0007). The strongest independent predictor of peak Vo(2) was the change in A-Vo(2) Diff from rest to peak exercise (A-Vo(2) Diff reserve) for both HFPEF patients (partial correlate, 0.58; standardized β coefficient, 0.66; p = 0.0002) and healthy controls (partial correlate, 0.61; standardized β coefficient, 0.41; p = 0.005).Both reduced cardiac output and A-Vo(2) Diff contribute significantly to the severe exercise intolerance in elderly HFPEF patients. The finding that A-Vo(2) Diff reserve is an independent predictor of peak Vo(2) suggests that peripheral, noncardiac factors are important contributors to exercise intolerance in these patients.CONCLUSIONSBoth reduced cardiac output and A-Vo(2) Diff contribute significantly to the severe exercise intolerance in elderly HFPEF patients. The finding that A-Vo(2) Diff reserve is an independent predictor of peak Vo(2) suggests that peripheral, noncardiac factors are important contributors to exercise intolerance in these patients.
The purpose of this study was to determine the mechanisms responsible for reduced aerobic capacity (peak Vo(2)) in patients with heart failure with preserved ejection fraction (HFPEF). HFPEF is the predominant form of heart failure in older persons. Exercise intolerance is the primary symptom among patients with HFPEF and a major determinant of reduced quality of life. In contrast to patients with heart failure and reduced ejection fraction, the mechanism of exercise intolerance in HFPEF is less well understood. Left ventricular volumes (2-dimensional echocardiography), cardiac output, Vo(2), and calculated arterial-venous oxygen content difference (A-Vo(2) Diff) were measured at rest and during incremental, exhaustive upright cycle exercise in 48 HFPEF patients (age 69 ± 6 years) and 25 healthy age-matched controls. In HFPEF patients compared with healthy controls, Vo(2) was reduced at peak exercise (14.3 ± 0.5 ml·kg·min(-1) vs. 20.4 ± 0.6 ml·kg·min(-1); p < 0.0001) and was associated with a reduced peak cardiac output (6.3 ± 0.2 l·min(-1) vs. 7.6 ± 0.2 l·min(-1); p < 0.0001) and A-Vo(2) Diff (17 ± 0.4 ml·dl(-1) vs. 19 ± 0.4 ml·dl(-1), p < 0.0007). The strongest independent predictor of peak Vo(2) was the change in A-Vo(2) Diff from rest to peak exercise (A-Vo(2) Diff reserve) for both HFPEF patients (partial correlate, 0.58; standardized β coefficient, 0.66; p = 0.0002) and healthy controls (partial correlate, 0.61; standardized β coefficient, 0.41; p = 0.005). Both reduced cardiac output and A-Vo(2) Diff contribute significantly to the severe exercise intolerance in elderly HFPEF patients. The finding that A-Vo(2) Diff reserve is an independent predictor of peak Vo(2) suggests that peripheral, noncardiac factors are important contributors to exercise intolerance in these patients.
Author Kitzman, Dalane W
Haykowsky, Mark J
John, Jerry M
Brubaker, Peter H
Morgan, Timothy M
Stewart, Kathryn P
Author_xml – sequence: 1
  givenname: Mark J
  surname: Haykowsky
  fullname: Haykowsky, Mark J
  organization: Faculty of Rehabilitation Medicine, University of Alberta, Edmonton, Alberta, Canada
– sequence: 2
  givenname: Peter H
  surname: Brubaker
  fullname: Brubaker, Peter H
– sequence: 3
  givenname: Jerry M
  surname: John
  fullname: John, Jerry M
– sequence: 4
  givenname: Kathryn P
  surname: Stewart
  fullname: Stewart, Kathryn P
– sequence: 5
  givenname: Timothy M
  surname: Morgan
  fullname: Morgan, Timothy M
– sequence: 6
  givenname: Dalane W
  surname: Kitzman
  fullname: Kitzman, Dalane W
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21737017$$D View this record in MEDLINE/PubMed
BookMark eNpNkD1PwzAYhC1URD_gDzAgb0wJthPbyYjKp1SJBebI2K-po8QptgP039NCkZju0enuhpujiR88IHROSU4JFVdt3iqtc0YozQnLCedHaEY5r7KC13Lyj6doHmNLCBEVrU_QlFFZSELlDL3dQILQO698iniwGL4gaBcBO5-GDoLyes8YOgOh2-I1qJCwVa4bA-CNSg72zU-X1ngTIEL4AIOhBZ3c4LEN6gdO0bFVXYSzgy7Qy93t8_IhWz3dPy6vV5kWRKas5NpQ0CUFK6kxlkFhia10LUDWpa4tKQtdKWU4F6oShEtuhawpMTvfUsoW6PJ3dxOG9xFianoXNXSd8jCMsakkl4zxUuySF4fk-NqDaTbB9Spsm79v2Dczu2tY
CitedBy_id crossref_primary_10_3389_fmed_2021_692029
crossref_primary_10_1001_jama_2023_0675
crossref_primary_10_1016_j_cjca_2025_03_015
crossref_primary_10_1016_j_ijcard_2013_05_006
crossref_primary_10_1016_j_echo_2015_06_004
crossref_primary_10_1016_j_ijcard_2016_07_135
crossref_primary_10_1161_CIRCRESAHA_119_313572
crossref_primary_10_2217_fca_2017_0023
crossref_primary_10_3390_jcm12134438
crossref_primary_10_1016_j_ijcard_2025_133320
crossref_primary_10_1016_j_jacc_2014_05_030
crossref_primary_10_3390_biomedicines12112589
crossref_primary_10_1152_japplphysiol_00374_2015
crossref_primary_10_1016_j_jjcc_2021_11_003
crossref_primary_10_1161_CIRCHEARTFAILURE_117_004129
crossref_primary_10_1161_CIRCHEARTFAILURE_112_966564
crossref_primary_10_1161_CIRCULATIONAHA_119_041818
crossref_primary_10_1007_s11897_013_0166_4
crossref_primary_10_1007_s10741_022_10259_1
crossref_primary_10_1016_j_ccl_2016_06_001
crossref_primary_10_1016_j_hrtlng_2021_02_004
crossref_primary_10_1152_japplphysiol_00013_2019
crossref_primary_10_1016_j_jbmt_2024_03_065
crossref_primary_10_5339_gcsp_2014_40
crossref_primary_10_1002_ehf2_14070
crossref_primary_10_1016_j_jacc_2012_02_055
crossref_primary_10_1155_2024_2735577
crossref_primary_10_3390_jcdd9080241
crossref_primary_10_1016_j_jchf_2017_10_014
crossref_primary_10_5339_gcsp_2015_12
crossref_primary_10_1016_j_pcad_2016_06_002
crossref_primary_10_1016_j_jcmg_2018_10_039
crossref_primary_10_1007_s10741_017_9603_x
crossref_primary_10_1007_s10741_025_10504_3
crossref_primary_10_1177_2040622313480382
crossref_primary_10_3389_fcvm_2023_1098395
crossref_primary_10_1111_eci_13261
crossref_primary_10_1152_ajpregu_00290_2018
crossref_primary_10_1161_CIRCHEARTFAILURE_114_001825
crossref_primary_10_3389_fcvm_2024_1431787
crossref_primary_10_4081_cardio_2025_67
crossref_primary_10_1016_j_amjcard_2024_09_005
crossref_primary_10_1007_s11886_014_0501_8
crossref_primary_10_1016_j_jacc_2013_10_007
crossref_primary_10_1016_j_jsha_2012_01_004
crossref_primary_10_1161_CIRCRESAHA_118_312669
crossref_primary_10_1007_s10741_021_10114_9
crossref_primary_10_1016_j_cpcardiol_2015_12_002
crossref_primary_10_1016_j_jchf_2015_05_010
crossref_primary_10_1097_HCO_0b013e3283512035
crossref_primary_10_1152_ajpheart_00414_2017
crossref_primary_10_1155_2013_130724
crossref_primary_10_1007_s11936_012_0187_4
crossref_primary_10_1007_s12265_025_10699_8
crossref_primary_10_1016_j_jchf_2018_03_003
crossref_primary_10_1249_MSS_0000000000000388
crossref_primary_10_5507_bp_2014_066
crossref_primary_10_1016_j_jacc_2015_07_067
crossref_primary_10_1161_CIRCHEARTFAILURE_114_001915
crossref_primary_10_1016_j_hfc_2014_08_009
crossref_primary_10_1016_j_lfs_2024_122594
crossref_primary_10_1016_j_cardfail_2021_04_013
crossref_primary_10_1097_CRD_0000000000000454
crossref_primary_10_1002_ejhf_2747
crossref_primary_10_1007_s11936_021_00904_7
crossref_primary_10_1161_JAHA_121_024582
crossref_primary_10_1152_japplphysiol_00798_2022
crossref_primary_10_1093_eurjcn_zvac004
crossref_primary_10_1016_j_ijcard_2014_11_106
crossref_primary_10_1093_eurjpc_zwae332
crossref_primary_10_1007_s11897_012_0087_7
crossref_primary_10_1016_j_jacc_2013_02_013
crossref_primary_10_1161_CIRCULATIONAHA_115_017119
crossref_primary_10_1161_CIRCHEARTFAILURE_122_010003
crossref_primary_10_1186_s13643_024_02529_w
crossref_primary_10_1016_j_jacc_2023_01_049
crossref_primary_10_1177_2047487317706587
crossref_primary_10_3390_jcdd9030087
crossref_primary_10_7556_jaoa_2015_089
crossref_primary_10_1016_j_jacc_2013_04_033
crossref_primary_10_1002_jmri_25379
crossref_primary_10_1016_j_amjmed_2018_07_009
crossref_primary_10_1016_j_cjca_2016_06_001
crossref_primary_10_1111_jgs_16050
crossref_primary_10_1152_japplphysiol_00049_2015
crossref_primary_10_1016_j_cjca_2018_08_012
crossref_primary_10_1016_j_ijcard_2017_10_114
crossref_primary_10_1161_JAHA_114_001293
crossref_primary_10_1161_CIRCULATIONAHA_115_018954
crossref_primary_10_1093_eurjpc_zwae363
crossref_primary_10_3389_fcvm_2025_1598878
crossref_primary_10_1016_j_hrtlng_2022_03_013
crossref_primary_10_1016_j_jcmg_2017_08_021
crossref_primary_10_3389_fcvm_2021_631807
crossref_primary_10_1016_j_bbadis_2021_166208
crossref_primary_10_1007_s00395_024_01034_4
crossref_primary_10_1177_2047487315622093
crossref_primary_10_1007_s10741_023_10309_2
crossref_primary_10_1016_j_jacc_2019_01_072
crossref_primary_10_1016_j_jacc_2011_09_015
crossref_primary_10_1016_j_cardfail_2024_06_007
crossref_primary_10_1016_j_hfc_2017_02_012
crossref_primary_10_1152_japplphysiol_00747_2017
crossref_primary_10_1152_japplphysiol_00918_2023
crossref_primary_10_1016_j_hfc_2014_04_001
crossref_primary_10_1007_s11886_020_01318_w
crossref_primary_10_1002_ejhf_1739
crossref_primary_10_1016_j_chest_2019_04_109
crossref_primary_10_1016_j_jacc_2017_09_006
crossref_primary_10_1161_CIRCHEARTFAILURE_123_011693
crossref_primary_10_1161_CIRCHEARTFAILURE_117_004281
crossref_primary_10_1016_j_jacc_2011_11_062
crossref_primary_10_1016_j_cger_2016_01_002
crossref_primary_10_1016_j_jacc_2016_04_052
crossref_primary_10_1111_echo_12928
crossref_primary_10_1161_CIRCHEARTFAILURE_117_003862
crossref_primary_10_1161_JAHA_116_003248
crossref_primary_10_1038_s41598_022_09637_4
crossref_primary_10_1016_j_exger_2021_111626
crossref_primary_10_1097_HCO_0b013e32835164e3
crossref_primary_10_1016_j_hlc_2017_07_002
crossref_primary_10_1038_s41598_023_31381_6
crossref_primary_10_1016_j_jchf_2025_02_024
crossref_primary_10_1016_j_cardfail_2024_01_015
crossref_primary_10_1111_chf_12013
crossref_primary_10_1097_PHM_0000000000000312
crossref_primary_10_3390_ijms23158631
crossref_primary_10_2196_resprot_8865
crossref_primary_10_1113_EP088835
crossref_primary_10_1186_s40798_024_00740_6
crossref_primary_10_1002_ejhf_2146
crossref_primary_10_1007_s10741_022_10219_9
crossref_primary_10_1016_j_chest_2023_06_019
crossref_primary_10_1016_j_jcmg_2018_12_034
crossref_primary_10_1161_CIRCHEARTFAILURE_114_001551
crossref_primary_10_1016_j_amjcard_2021_03_011
crossref_primary_10_1002_ejhf_239
crossref_primary_10_1016_j_jacc_2015_10_096
crossref_primary_10_1161_JAHA_116_005434
crossref_primary_10_1161_CIRCHEARTFAILURE_120_007198
crossref_primary_10_1002_ejhf_1059
crossref_primary_10_1002_ejhf_913
crossref_primary_10_1097_CRD_0000000000000416
crossref_primary_10_1161_CIRCULATIONAHA_119_041886
crossref_primary_10_3389_fcvm_2022_1016452
crossref_primary_10_1093_eurheartj_ehw241
crossref_primary_10_1111_echo_13440
crossref_primary_10_1161_JAHA_120_016635
crossref_primary_10_1038_s41598_021_03974_6
crossref_primary_10_1159_000350068
crossref_primary_10_1113_JP280899
crossref_primary_10_23736_S1824_4785_17_02930_2
crossref_primary_10_1111_chf_12005
crossref_primary_10_1161_CIRCULATIONAHA_117_029058
crossref_primary_10_1016_j_ahj_2012_09_002
crossref_primary_10_1016_j_cardfail_2012_06_530
crossref_primary_10_1016_j_jchf_2019_01_006
crossref_primary_10_1016_j_ijcard_2012_03_093
crossref_primary_10_1016_j_cardfail_2014_07_010
crossref_primary_10_1186_s12933_023_01835_2
crossref_primary_10_1007_s11897_018_0383_y
crossref_primary_10_1016_j_rehab_2012_03_005
crossref_primary_10_1002_ejhf_3105
crossref_primary_10_1038_nrcardio_2014_83
crossref_primary_10_1016_j_cardfail_2019_02_015
crossref_primary_10_1016_j_jacc_2021_07_014
crossref_primary_10_3389_fphys_2022_967817
crossref_primary_10_1161_CIRCULATIONAHA_116_021884
crossref_primary_10_1016_j_ihj_2021_06_012
crossref_primary_10_1016_j_ahj_2014_08_010
crossref_primary_10_1016_j_jchf_2015_07_005
crossref_primary_10_1016_j_hfc_2014_03_001
crossref_primary_10_1152_japplphysiol_00045_2023
crossref_primary_10_1186_s12872_022_02792_6
crossref_primary_10_1161_CIRCULATIONAHA_114_014420
crossref_primary_10_1016_j_jacadv_2024_101101
crossref_primary_10_1002_ejhf_1956
crossref_primary_10_1016_j_jchf_2020_03_008
crossref_primary_10_1186_s12933_018_0688_x
crossref_primary_10_1016_j_cjco_2025_01_004
crossref_primary_10_1016_j_amjcard_2016_10_026
crossref_primary_10_1016_j_ccl_2021_12_009
crossref_primary_10_1016_j_cardfail_2016_10_007
crossref_primary_10_1016_j_jacc_2023_02_012
crossref_primary_10_1161_CIR_0000000000001122
crossref_primary_10_1007_s11897_015_0257_5
crossref_primary_10_2217_fca_2021_0135
crossref_primary_10_1177_2047487316668150
crossref_primary_10_1007_s00392_018_1344_x
crossref_primary_10_1016_j_jacc_2013_10_063
crossref_primary_10_1016_j_cjca_2015_12_021
crossref_primary_10_1161_CIRCHEARTFAILURE_112_000216
crossref_primary_10_1016_j_cardfail_2021_10_010
crossref_primary_10_1161_CIRCHEARTFAILURE_117_004750
crossref_primary_10_1093_eurjcn_zvac096
crossref_primary_10_1161_CIRCHEARTFAILURE_124_012512
crossref_primary_10_1007_s11886_018_1056_x
crossref_primary_10_1007_s40256_017_0219_2
crossref_primary_10_1016_j_jcmg_2022_12_009
crossref_primary_10_1113_EP090674
crossref_primary_10_1161_CIRCIMAGING_116_005467
crossref_primary_10_5339_gcsp_2012_10
crossref_primary_10_3390_jcm11102692
crossref_primary_10_1093_eurheartj_eht117
crossref_primary_10_1007_s11897_016_0277_9
crossref_primary_10_1111_echo_15648
crossref_primary_10_1111_echo_14799
crossref_primary_10_1016_j_ccl_2022_06_001
crossref_primary_10_1016_j_ccl_2022_06_003
crossref_primary_10_1016_j_hfc_2019_08_008
crossref_primary_10_1016_j_cardfail_2015_11_004
crossref_primary_10_1016_j_jacc_2011_02_054
crossref_primary_10_1007_s10741_022_10233_x
crossref_primary_10_1093_eurjhf_hft026
crossref_primary_10_1161_CIRCULATIONAHA_122_061828
crossref_primary_10_1016_j_cardfail_2014_01_005
crossref_primary_10_1161_CIRCHEARTFAILURE_112_967919
crossref_primary_10_1007_s10741_025_10545_8
crossref_primary_10_1002_ejhf_2337
crossref_primary_10_1161_JAHA_121_026009
crossref_primary_10_1016_j_ahj_2016_01_002
crossref_primary_10_1016_j_ccl_2022_06_010
crossref_primary_10_3390_ijerph19020709
crossref_primary_10_1016_j_jchf_2016_06_002
crossref_primary_10_1038_s41598_024_61529_x
crossref_primary_10_1002_ejhf_184
crossref_primary_10_1007_s10741_019_09853_7
crossref_primary_10_3389_fcvm_2021_678614
crossref_primary_10_1155_2017_4865756
crossref_primary_10_1161_CIRCULATIONAHA_117_031528
crossref_primary_10_1016_j_chest_2020_05_552
crossref_primary_10_1152_ajpheart_00469_2015
crossref_primary_10_1016_j_jchf_2016_03_022
crossref_primary_10_1016_j_jjcc_2023_06_014
crossref_primary_10_1111_jch_13210
crossref_primary_10_1111_jgs_14940
crossref_primary_10_1161_CIRCRESAHA_125_325531
crossref_primary_10_1016_j_jacc_2011_08_048
crossref_primary_10_1161_CIRCRESAHA_125_325534
crossref_primary_10_1097_HCO_0000000000000824
crossref_primary_10_1113_EP086275
crossref_primary_10_1161_CIRCHEARTFAILURE_112_969071
crossref_primary_10_1161_CIRCHEARTFAILURE_118_004969
crossref_primary_10_3390_nu12010211
crossref_primary_10_1016_j_yjmcc_2015_02_025
crossref_primary_10_1016_j_crphys_2025_100153
crossref_primary_10_1007_s10147_018_1315_2
crossref_primary_10_1161_CIRCULATIONAHA_118_036259
crossref_primary_10_1186_s12933_021_01314_6
crossref_primary_10_1001_jama_2023_1053
crossref_primary_10_1007_s00421_019_04222_6
crossref_primary_10_1161_CIRCHEARTFAILURE_114_001192
crossref_primary_10_1136_heartjnl_2019_314797
crossref_primary_10_1186_s40959_019_0038_5
crossref_primary_10_4081_cardio_2025_71
crossref_primary_10_1016_j_apmr_2016_08_481
crossref_primary_10_3389_fphys_2020_572355
crossref_primary_10_1097_HCR_0000000000000459
crossref_primary_10_1186_s40814_024_01580_7
crossref_primary_10_3390_jcm12185817
crossref_primary_10_1002_ejhf_2313
crossref_primary_10_1016_j_metabol_2019_05_007
crossref_primary_10_1016_j_jacc_2022_07_011
crossref_primary_10_1016_j_jacc_2011_12_013
crossref_primary_10_1007_s10741_018_9714_z
crossref_primary_10_1016_j_cardfail_2021_02_011
crossref_primary_10_1016_j_jjcc_2022_09_004
crossref_primary_10_1097_CRD_0000000000000124
crossref_primary_10_1007_s00395_022_00958_z
crossref_primary_10_1016_j_jacc_2011_07_024
crossref_primary_10_1016_j_jacc_2012_04_012
crossref_primary_10_1002_phy2_174
crossref_primary_10_1016_j_jacc_2020_10_022
crossref_primary_10_1007_s11897_018_0408_6
crossref_primary_10_1016_j_cpcardiol_2019_03_006
crossref_primary_10_1016_j_amjcard_2012_08_015
crossref_primary_10_1097_PHM_0000000000001125
crossref_primary_10_3390_jcm12093341
crossref_primary_10_1016_j_jacc_2015_11_045
crossref_primary_10_1097_JCN_0000000000000982
crossref_primary_10_1152_japplphysiol_01127_2014
crossref_primary_10_1371_journal_pone_0255682
crossref_primary_10_1016_j_jcmg_2023_06_014
crossref_primary_10_1161_CIRCIMAGING_112_980037
crossref_primary_10_1111_echo_13709
crossref_primary_10_1016_j_amjcard_2013_12_031
crossref_primary_10_1681_ASN_2020091319
crossref_primary_10_1146_annurev_med_042220_022745
crossref_primary_10_1097_HCR_0000000000000481
crossref_primary_10_1002_ehf2_13382
crossref_primary_10_1161_CIRCULATIONAHA_116_024822
crossref_primary_10_1007_s10741_020_09996_y
crossref_primary_10_1016_j_amjcard_2020_03_006
crossref_primary_10_1016_j_echo_2022_03_006
crossref_primary_10_1016_j_pcad_2022_10_005
crossref_primary_10_1016_j_ccl_2022_07_001
crossref_primary_10_1016_j_jchf_2015_01_010
crossref_primary_10_1002_ejhf_2093
crossref_primary_10_1016_j_jchf_2016_03_011
crossref_primary_10_1016_j_cardfail_2020_12_025
crossref_primary_10_1016_j_echo_2018_12_002
crossref_primary_10_1016_j_jchf_2015_12_013
crossref_primary_10_4330_wjc_v12_i1_7
crossref_primary_10_1016_j_ejim_2014_09_017
crossref_primary_10_1093_ehjci_jeae152
crossref_primary_10_1161_CIRCHEARTFAILURE_114_001966
crossref_primary_10_1016_j_jchf_2018_06_002
crossref_primary_10_1161_HYPERTENSIONAHA_111_00163
ContentType Journal Article
Copyright Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.jacc.2011.02.055
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1558-3597
ExternalDocumentID 21737017
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIA NIH HHS
  grantid: R37 AG018915
– fundername: NIA NIH HHS
  grantid: R01 AG012257
– fundername: NIA NIH HHS
  grantid: R01AG12257
– fundername: NCRR NIH HHS
  grantid: MO1RR07122
– fundername: NIA NIH HHS
  grantid: R37AG18915
– fundername: NIA NIH HHS
  grantid: R01 AG018915
– fundername: NCRR NIH HHS
  grantid: M01 RR007122
– fundername: NHLBI NIH HHS
  grantid: T32 HL076132
– fundername: NIA NIH HHS
  grantid: P30AG21332
– fundername: NHLBI NIH HHS
  grantid: 5T32HL076132-02
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
18M
1B1
1P~
1~.
1~5
2WC
4.4
457
4G.
53G
5GY
5RE
5VS
6PF
7-5
71M
8P~
AABNK
AABVL
AAEDT
AAEDW
AAIKJ
AAKUH
AALRI
AAOAW
AAQFI
AAXUO
ABBQC
ABFNM
ABFRF
ABLJU
ABMAC
ABOCM
ABWVN
ABXDB
ACGFO
ACGFS
ACIUM
ACJTP
ACPRK
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADVLN
AEFWE
AEKER
AENEX
AEUPX
AEVXI
AEXQZ
AFCTW
AFETI
AFFNX
AFPUW
AFRAH
AFRHN
AFTJW
AGCQF
AGHFR
AGYEJ
AHMBA
AIGII
AITUG
AJRQY
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
BAWUL
BLXMC
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EBS
ECM
EFKBS
EIF
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FNPLU
G-Q
GBLVA
GX1
H13
HVGLF
HZ~
IHE
IXB
J1W
K-O
KQ8
L7B
MO0
N9A
NPM
O-L
O9-
OA.
OAUVE
OK1
OL~
OZT
P-8
P-9
P2P
PC.
PQQKQ
PROAC
Q38
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SSZ
TR2
UNMZH
UV1
W8F
WH7
WOQ
WOW
YYM
YZZ
Z5R
7X8
EFLBG
~HD
ID FETCH-LOGICAL-c607t-45cd1ec41ef71ddf2e3f0f8c96e794c9f043c8aad556a860575f67910d43cf112
IEDL.DBID 7X8
ISICitedReferencesCount 343
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000292453200008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1558-3597
IngestDate Sun Nov 09 05:32:25 EST 2025
Mon Jul 21 05:50:57 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
License Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c607t-45cd1ec41ef71ddf2e3f0f8c96e794c9f043c8aad556a860575f67910d43cf112
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.clinicalkey.com/#!/content/1-s2.0-S0735109711015476
PMID 21737017
PQID 875722546
PQPubID 23479
ParticipantIDs proquest_miscellaneous_875722546
pubmed_primary_21737017
PublicationCentury 2000
PublicationDate 2011-07-12
PublicationDateYYYYMMDD 2011-07-12
PublicationDate_xml – month: 07
  year: 2011
  text: 2011-07-12
  day: 12
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of the American College of Cardiology
PublicationTitleAlternate J Am Coll Cardiol
PublicationYear 2011
References 21737018 - J Am Coll Cardiol. 2011 Jul 12;58(3):275-7. doi: 10.1016/j.jacc.2011.02.054.
22133861 - J Am Coll Cardiol. 2011 Dec 6;58(24):2547-8; author reply 2548-9. doi: 10.1016/j.jacc.2011.08.048.
References_xml – reference: 22133861 - J Am Coll Cardiol. 2011 Dec 6;58(24):2547-8; author reply 2548-9. doi: 10.1016/j.jacc.2011.08.048.
– reference: 21737018 - J Am Coll Cardiol. 2011 Jul 12;58(3):275-7. doi: 10.1016/j.jacc.2011.02.054.
SSID ssj0006819
Score 2.5345898
Snippet The purpose of this study was to determine the mechanisms responsible for reduced aerobic capacity (peak Vo(2)) in patients with heart failure with preserved...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 265
SubjectTerms Aged
Cardiac Output
Echocardiography
Exercise Test
Exercise Tolerance
Female
Heart Failure - diagnostic imaging
Heart Failure - physiopathology
Humans
Male
Oxygen - blood
Oxygen Consumption
Stroke Volume
Ventricular Function, Left
Title Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction
URI https://www.ncbi.nlm.nih.gov/pubmed/21737017
https://www.proquest.com/docview/875722546
Volume 58
WOSCitedRecordID wos000292453200008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07T8MwELaAIsTC-1Fe8sAayNOPCSGgYmnVAaRukWv7UKsqKU1A4t_jS1xgQQwsURQpUWSfz9_5vruPkEsF0mQmkgFT1gUodjwOpMxclAIMVKp1qrlqxCb4YCBGIzn03JzK0yqXPrFx1KbUeEZ-jY3XY2zefjN_DVA0CpOrXkFjlXQSh2SQ0cVH383CmWh0PdyOKYLEAWdfM9PSu6ZKa9_BM74Ks-x3hNnsNL3tf_7jDtnyEJPetjaxS1ZssUc2-j6Jvk9e7n9QYGgJdCm7RCdFXc4sSm3gPbWo4D37oCh6XVNQE6SwU9-JtaJ4hEuRR4ukSUPttGF1FRQWbbHEAXnuPTzdPQZebyHQLOR1kGbaRFankQUeGQOxTSAEoSWzbtVqCWGaaKGUyTKmBEOkB4w7vGHcc3DA7ZCsFWVhjwnVihkO1uEJC6kUDEuKxjFYId33Qy26hC5HMHf2jEkKVdjyrcq_xrBLjtpZyOdt343cRU8Jdx7k5O-XT8lme_jLgyg-Ix1wa9mek3X9Xk-qxUVjJ-46GPY_AZZdy4I
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Determinants+of+exercise+intolerance+in+elderly+heart+failure+patients+with+preserved+ejection+fraction&rft.jtitle=Journal+of+the+American+College+of+Cardiology&rft.au=Haykowsky%2C+Mark+J&rft.au=Brubaker%2C+Peter+H&rft.au=John%2C+Jerry+M&rft.au=Stewart%2C+Kathryn+P&rft.date=2011-07-12&rft.issn=1558-3597&rft.eissn=1558-3597&rft.volume=58&rft.issue=3&rft.spage=265&rft_id=info:doi/10.1016%2Fj.jacc.2011.02.055&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1558-3597&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1558-3597&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1558-3597&client=summon